搜索筛选:
搜索耗时0.0824秒,为你在为你在102,285,761篇论文里面共找到 4 篇相符的论文内容
发布年度:
Are the data on quality of life and patient reported outcomes from clinical trials of metastatic non
[期刊论文] 作者：Vera Hirsh,
来源：世界临床肿瘤学杂志 年份：2013
Majority of the patients with advanced non-small-cell lung cancer(NSCLC)experience two or more disease related symptoms,which may have a negative impact on thei...
[期刊论文] 作者：Vera Hirsh,
来源：世界临床肿瘤学杂志 年份：2011
In recent years,as we have a better knowledge and understanding of the biology of non small cell lung carcinoma(NSCLC),which leads us to targeting biomarkers dr...
Randomized Phase 3 Trial to Assess Long-Term Safety of Darbepoetin alfa in Patients With Non-Small C
[会议论文] 作者：Li Zhang,Pere Gascón,Carlos H.Barrios,Jesús Cárdenas Sánchez,David Gordon,David Henry,Vera Hirsh,Shona,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
...
Randomized Phase 3 Trial to Assess Long-Term Safety of Darbepoetin alfa in Patients With Non-Small C
[会议论文] 作者：Li Zhang,Pere Gascón,Carlos H.Barrios,Jesús Cárdenas Sánchez,David Gordon,David Henry,Vera Hirsh,Shona,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
目的: Controlled trials have shown that erythropoiesis-stimulating agents (ESAs) raise hemoglobin (Hb)and reduce transfusions in patients with CIA.In a few trials, increased mortality and/or tumor progr...
相关搜索：
